Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Oslo Bors  >  Borregaard ASA    BRG   NO0010657505

BORREGAARD ASA

(BRG)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 10/23 07:34:14 am
130.4 NOK   +2.19%
10/22BORREGAARD : Financial calendar
AQ
10/21BORREGAARD ASA : EBITDA of NOK 266 million in the 3rd quarter
PU
10/08BORREGAARD ASA : Invitation to Q3 2020 announcement
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Borregaard ASA: Borregaard's Capital Markets Day – strategy unchanged, expansion investments in ramp-up phase

share with twitter share with LinkedIn share with facebook
09/17/2020 | 02:00am EDT

17 September 2020: Borregaard ASA (“Borregaard”, OSE ticker: BRG)

Borregaard’s Capital Markets Day will take place today, starting at 09:00 and ending at 11:30 CET. The event can be followed via webcast at https://www.borregaard.com/Investor-Relations/Latest-IR-News/Capital-Markets-Day-2020/(language)/eng-GB. The written material supporting the presentations is enclosed.

During his presentation, Borregaard’s President and CEO, Per A. Sørlie, will give an update on the strategic priorities in light of the recent expansion investments and the reduced availability of lignin raw material.

- Our strategy for specialisation and diversification remains unchanged, and we will continue to pursue market opportunities based on our unique biorefinery concept. The recent expansion investments will enable us to execute the strategy for increased value creation, and our sustainable business model gives our products an attractive edge in competition with alternative materials, says Per A. Sørlie.

Borregaard’s CFO, Per Bjarne Lyngstad, will reiterate current financial targets and illustrate the effect of recent and ongoing investment projects on future earnings and key financial numbers. Market updates will be presented by the executive vice presidents in charge of BioSolutions, BioMaterials and Cellulose fibrils.

Borregaard ASA
Sarpsborg, 17 September 2020

Contact:
Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

 

Attachment

  • Borregaard CMD 2020

© OMX, source OMX


share with twitter share with LinkedIn share with facebook
All news about BORREGAARD ASA
10/22BORREGAARD : Financial calendar
AQ
10/21BORREGAARD ASA : EBITDA of NOK 266 million in the 3rd quarter
PU
10/08BORREGAARD ASA : Invitation to Q3 2020 announcement
PU
10/08BORREGAARD ASA : Invitation to Q3 2020 announcement
AQ
09/22BORREGAARD ASA : Stock options exercised, repurchase of own shares
PU
09/22BORREGAARD ASA : Stock options exercised, repurchase of own shares
AQ
09/22BORREGAARD ASA : Stock options exercised, repurchase of own shares
AQ
09/21BORREGAARD ASA : Mandatory notification of trade – party related to primar..
PU
09/21BORREGAARD ASA : Mandatory notification of trade - party related to primary insi..
AQ
09/21BORREGAARD ASA : Mandatory notification of trade – party related to primar..
AQ
More news
Financials
Sales 2020 5 205 M 565 M 565 M
Net income 2020 522 M 56,6 M 56,6 M
Net Debt 2020 1 796 M 195 M 195 M
P/E ratio 2020 31,9x
Yield 2020 1,89%
Capitalization 12 711 M 1 378 M 1 380 M
EV / Sales 2020 2,79x
EV / Sales 2021 2,68x
Nbr of Employees -
Free-Float 92,4%
Chart BORREGAARD ASA
Duration : Period :
Borregaard ASA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BORREGAARD ASA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 155,00 NOK
Last Close Price 127,60 NOK
Spread / Highest target 29,3%
Spread / Average Target 21,5%
Spread / Lowest Target 9,72%
EPS Revisions
Managers
NameTitle
Per Arthur Sørlie President & Chief Executive Officer
Jan Anders Oksum Chairman
Per Bjarne Lyngstad Chief Financial Officer & Senior Vice President
Kristin Misund Senior Vice President-Business Development, R&D
Terje Andersen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BORREGAARD ASA34.32%1 378
ECOLAB INC.6.16%58 467
GIVAUDAN SA27.25%39 253
SIKA AG28.79%36 606
EMS-CHEMIE HOLDING AG30.71%21 459
SYMRISE AG22.07%18 344